Viewing Study NCT02805660


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-06-27 @ 7:23 PM
Study NCT ID: NCT02805660
Status: TERMINATED
Last Update Posted: 2021-04-06
First Post: 2016-06-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC
Sponsor:
Organization: